HEADER CALCIUM BINDING PROTEIN 30-DEC-11 2LNK TITLE SOLUTION STRUCTURE OF CA-BOUND S100A4 IN COMPLEX WITH NON-MUSCLE TITLE 2 MYOSIN IIA COMPND MOL_ID: 1; COMPND 2 MOLECULE: MYOSIN HEAVY CHAIN, NON-MUSCLE IIA; COMPND 3 CHAIN: C; COMPND 4 FRAGMENT: UNP RESIDUES 1897-1935; COMPND 5 SYNONYM: MYOSIN-9, CELLULAR MYOSIN HEAVY CHAIN, TYPE A, MYOSIN HEAVY COMPND 6 CHAIN 9, MYOSIN HEAVY CHAIN, NON-MUSCLE IIA, NON-MUSCLE MYOSIN HEAVY COMPND 7 CHAIN A, NMMHC-A, NON-MUSCLE MYOSIN HEAVY CHAIN IIA, NMMHC II-A, COMPND 8 NMMHC-IIA; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: PROTEIN S100-A4; COMPND 12 CHAIN: A, B; COMPND 13 SYNONYM: CALVASCULIN, METASTASIN, PLACENTAL CALCIUM-BINDING PROTEIN, COMPND 14 PROTEIN MTS1, S100 CALCIUM-BINDING PROTEIN A4; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 GENE: S100A4, CAPL, MTS1; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 13 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS EF-HAND, CALCIUM BINDING, ALL ALPHA, METAL BINDING PROTEIN, CALCIUM KEYWDS 2 BINDING PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR I.L.BARSUKOV,P.R.ELLIOTT REVDAT 2 14-JUN-23 2LNK 1 REMARK SEQADV REVDAT 1 25-APR-12 2LNK 0 JRNL AUTH P.R.ELLIOTT,A.F.IRVINE,H.S.JUNG,K.TOZAWA,M.W.PASTOK, JRNL AUTH 2 R.PICONE,S.K.BADYAL,J.BASRAN,P.S.RUDLAND,R.BARRACLOUGH, JRNL AUTH 3 L.Y.LIAN,C.R.BAGSHAW,M.KRIAJEVSKA,I.L.BARSUKOV JRNL TITL ASYMMETRIC MODE OF CA(2+)-S100A4 INTERACTION WITH NONMUSCLE JRNL TITL 2 MYOSIN IIA GENERATES NANOMOLAR AFFINITY REQUIRED FOR JRNL TITL 3 FILAMENT REMODELING. JRNL REF STRUCTURE V. 20 654 2012 JRNL REFN ISSN 0969-2126 JRNL PMID 22483112 JRNL DOI 10.1016/J.STR.2012.02.002 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CCPN_ANALYSIS 2.1, CNS 1.1 REMARK 3 AUTHORS : CCPN (CCPN_ANALYSIS), BRUNGER, ADAMS, CLORE, GROS, REMARK 3 NILGES AND READ (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LNK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JAN-12. REMARK 100 THE DEPOSITION ID IS D_1000102602. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 313 REMARK 210 PH : 6.1 REMARK 210 IONIC STRENGTH : 0.02 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.5 MM PROTEIN_1, 1 MM [U-100% REMARK 210 13C; U-100% 15N] PROTEIN_2, 5 MM REMARK 210 CALCIUM ION, 20 MM MES, 20 MM REMARK 210 SODIUM CHLORIDE, 4 MM TCEP, 95% REMARK 210 H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D 1H-13C NOESY ALIPHATIC; 3D 1H REMARK 210 -13C NOESY AROMATIC; 2D 1H-1H REMARK 210 FILTERED NOESY; 3D 1H-15N NOESY; REMARK 210 3D CBCA(CO)NH; 3D HNCACB; 3D REMARK 210 HCCH-TOCSY; 3D HNCO; 2D 1H-1H REMARK 210 FILTERED TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 2.1, CNS 1.1, ARIA 1.2, REMARK 210 PROCHECKNMR REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-20 REMARK 465 RES C SSSEQI REMARK 465 MET A -11 REMARK 465 ARG A -10 REMARK 465 GLY A -9 REMARK 465 SER A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 MET B -11 REMARK 465 ARG B -10 REMARK 465 GLY B -9 REMARK 465 SER B -8 REMARK 465 HIS B -7 REMARK 465 HIS B -6 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 HIS B -3 REMARK 465 HIS B -2 REMARK 465 GLY B -1 REMARK 465 SER B 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HB3 ASP C 1925 HD3 LYS B 57 1.21 REMARK 500 O LEU B 46 H LYS B 48 1.59 REMARK 500 O GLU C 1913 H LEU C 1917 1.59 REMARK 500 O PHE B 16 HG SER B 20 1.59 REMARK 500 HZ3 LYS A 28 OD1 ASP A 71 1.60 REMARK 500 O PHE A 16 HG SER A 20 1.60 REMARK 500 OE1 GLU A 91 HZ1 LYS A 96 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 10 PHE C1928 CE1 PHE C1928 CZ 0.133 REMARK 500 10 PHE C1928 CZ PHE C1928 CE2 -0.116 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ARG C1898 55.74 175.54 REMARK 500 1 ARG C1933 -147.22 -113.24 REMARK 500 1 ARG A 40 -63.28 -90.00 REMARK 500 1 ASP A 51 -163.85 -101.15 REMARK 500 1 LEU A 58 -70.37 -57.84 REMARK 500 1 ASP A 63 88.52 -66.27 REMARK 500 1 ARG A 66 61.01 66.07 REMARK 500 1 PHE A 93 66.16 31.60 REMARK 500 1 ASP A 95 73.75 53.44 REMARK 500 1 LYS B 48 -55.49 -145.37 REMARK 500 1 ARG B 49 133.27 172.92 REMARK 500 1 PRO B 94 85.10 -66.75 REMARK 500 1 GLN B 97 110.68 69.68 REMARK 500 1 PRO B 98 29.40 -77.99 REMARK 500 1 ARG B 99 -108.30 -93.31 REMARK 500 2 ARG C1898 75.66 78.83 REMARK 500 2 ALA C1903 -71.61 -76.44 REMARK 500 2 ARG C1932 30.85 -67.48 REMARK 500 2 ARG C1933 -167.33 168.16 REMARK 500 2 CYS A 3 102.65 -50.86 REMARK 500 2 PHE A 16 -70.61 -46.96 REMARK 500 2 LYS A 48 -72.21 165.02 REMARK 500 2 ASP A 51 -167.74 -112.30 REMARK 500 2 PHE A 78 -70.26 -54.82 REMARK 500 2 ASP A 95 106.44 64.60 REMARK 500 2 CYS B 3 102.63 -52.35 REMARK 500 2 PHE B 16 -70.40 -48.59 REMARK 500 2 LYS B 48 11.04 -146.59 REMARK 500 2 ARG B 49 141.14 72.83 REMARK 500 2 ASP B 63 109.92 -57.60 REMARK 500 2 ASN B 68 -1.52 159.82 REMARK 500 2 PHE B 89 -60.28 -90.80 REMARK 500 2 ASP B 95 72.65 47.67 REMARK 500 2 GLN B 97 -179.78 66.31 REMARK 500 2 PRO B 98 93.52 -60.91 REMARK 500 2 ARG B 99 -66.55 -133.15 REMARK 500 2 LYS B 100 123.95 71.86 REMARK 500 3 ARG C1898 74.42 82.73 REMARK 500 3 ALA C1903 -71.00 -52.84 REMARK 500 3 ARG C1933 -178.95 66.72 REMARK 500 3 PHE A 16 -70.13 -50.03 REMARK 500 3 LYS A 48 -59.75 72.71 REMARK 500 3 ASP A 51 -168.54 -111.10 REMARK 500 3 ASP A 95 92.11 58.80 REMARK 500 3 LYS A 96 98.48 -166.06 REMARK 500 3 LYS B 48 -75.94 -132.95 REMARK 500 3 ARG B 49 149.06 173.42 REMARK 500 3 THR B 50 98.87 -67.24 REMARK 500 3 LEU B 62 -69.75 -92.34 REMARK 500 3 ASN B 68 35.71 77.83 REMARK 500 REMARK 500 THIS ENTRY HAS 367 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 7 ARG C1898 0.09 SIDE CHAIN REMARK 500 10 ARG C1898 0.09 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 18169 RELATED DB: BMRB DBREF 2LNK C 1897 1935 UNP P35579 MYH9_HUMAN 1897 1935 DBREF 2LNK A 1 101 UNP P26447 S10A4_HUMAN 1 101 DBREF 2LNK B 1 101 UNP P26447 S10A4_HUMAN 1 101 SEQADV 2LNK MET A -11 UNP P26447 EXPRESSION TAG SEQADV 2LNK ARG A -10 UNP P26447 EXPRESSION TAG SEQADV 2LNK GLY A -9 UNP P26447 EXPRESSION TAG SEQADV 2LNK SER A -8 UNP P26447 EXPRESSION TAG SEQADV 2LNK HIS A -7 UNP P26447 EXPRESSION TAG SEQADV 2LNK HIS A -6 UNP P26447 EXPRESSION TAG SEQADV 2LNK HIS A -5 UNP P26447 EXPRESSION TAG SEQADV 2LNK HIS A -4 UNP P26447 EXPRESSION TAG SEQADV 2LNK HIS A -3 UNP P26447 EXPRESSION TAG SEQADV 2LNK HIS A -2 UNP P26447 EXPRESSION TAG SEQADV 2LNK GLY A -1 UNP P26447 EXPRESSION TAG SEQADV 2LNK SER A 0 UNP P26447 EXPRESSION TAG SEQADV 2LNK MET B -11 UNP P26447 EXPRESSION TAG SEQADV 2LNK ARG B -10 UNP P26447 EXPRESSION TAG SEQADV 2LNK GLY B -9 UNP P26447 EXPRESSION TAG SEQADV 2LNK SER B -8 UNP P26447 EXPRESSION TAG SEQADV 2LNK HIS B -7 UNP P26447 EXPRESSION TAG SEQADV 2LNK HIS B -6 UNP P26447 EXPRESSION TAG SEQADV 2LNK HIS B -5 UNP P26447 EXPRESSION TAG SEQADV 2LNK HIS B -4 UNP P26447 EXPRESSION TAG SEQADV 2LNK HIS B -3 UNP P26447 EXPRESSION TAG SEQADV 2LNK HIS B -2 UNP P26447 EXPRESSION TAG SEQADV 2LNK GLY B -1 UNP P26447 EXPRESSION TAG SEQADV 2LNK SER B 0 UNP P26447 EXPRESSION TAG SEQRES 1 C 39 GLN ARG GLU LEU GLU ASP ALA THR GLU THR ALA ASP ALA SEQRES 2 C 39 MET ASN ARG GLU VAL SER SER LEU LYS ASN LYS LEU ARG SEQRES 3 C 39 ARG GLY ASP LEU PRO PHE VAL VAL PRO ARG ARG MET ALA SEQRES 1 A 113 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER MET SEQRES 2 A 113 ALA CYS PRO LEU GLU LYS ALA LEU ASP VAL MET VAL SER SEQRES 3 A 113 THR PHE HIS LYS TYR SER GLY LYS GLU GLY ASP LYS PHE SEQRES 4 A 113 LYS LEU ASN LYS SER GLU LEU LYS GLU LEU LEU THR ARG SEQRES 5 A 113 GLU LEU PRO SER PHE LEU GLY LYS ARG THR ASP GLU ALA SEQRES 6 A 113 ALA PHE GLN LYS LEU MET SER ASN LEU ASP SER ASN ARG SEQRES 7 A 113 ASP ASN GLU VAL ASP PHE GLN GLU TYR CYS VAL PHE LEU SEQRES 8 A 113 SER CYS ILE ALA MET MET CYS ASN GLU PHE PHE GLU GLY SEQRES 9 A 113 PHE PRO ASP LYS GLN PRO ARG LYS LYS SEQRES 1 B 113 MET ARG GLY SER HIS HIS HIS HIS HIS HIS GLY SER MET SEQRES 2 B 113 ALA CYS PRO LEU GLU LYS ALA LEU ASP VAL MET VAL SER SEQRES 3 B 113 THR PHE HIS LYS TYR SER GLY LYS GLU GLY ASP LYS PHE SEQRES 4 B 113 LYS LEU ASN LYS SER GLU LEU LYS GLU LEU LEU THR ARG SEQRES 5 B 113 GLU LEU PRO SER PHE LEU GLY LYS ARG THR ASP GLU ALA SEQRES 6 B 113 ALA PHE GLN LYS LEU MET SER ASN LEU ASP SER ASN ARG SEQRES 7 B 113 ASP ASN GLU VAL ASP PHE GLN GLU TYR CYS VAL PHE LEU SEQRES 8 B 113 SER CYS ILE ALA MET MET CYS ASN GLU PHE PHE GLU GLY SEQRES 9 B 113 PHE PRO ASP LYS GLN PRO ARG LYS LYS HELIX 1 1 ARG C 1898 THR C 1904 1 7 HELIX 2 2 THR C 1904 ARG C 1922 1 19 HELIX 3 3 CYS A 3 TYR A 19 1 17 HELIX 4 4 ASN A 30 LEU A 42 1 13 HELIX 5 5 PRO A 43 GLY A 47 5 5 HELIX 6 6 ALA A 53 ASP A 63 1 11 HELIX 7 7 ASP A 71 PHE A 89 1 19 HELIX 8 8 CYS B 3 TYR B 19 1 17 HELIX 9 9 LYS B 31 LEU B 42 1 12 HELIX 10 10 PRO B 43 GLY B 47 5 5 HELIX 11 11 ASP B 51 LEU B 62 1 12 HELIX 12 12 ASP B 71 GLY B 92 1 22 SHEET 1 A 2 LEU B 29 ASN B 30 0 SHEET 2 A 2 GLU B 69 VAL B 70 -1 O VAL B 70 N LEU B 29 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1